Jun 3, 2026 09:19AM
Jun 3, 2026 09:19AM
Mar 4, 2026 07:00AM
Feb 26, 2026 07:00AM
Feb 26, 2026 07:00AM
Dec 9, 2025 06:34AM
Dec 6, 2025 05:30PM TScan reports positive Phase 1 trial data for blood cancer treatment
Dec 6, 2025 05:30PM
Dec 6, 2025 05:30PM
Nov 12, 2025 07:00AM
Nov 4, 2025 06:03AM
Nov 3, 2025 06:30AM
Nov 3, 2025 06:30AM
May 6, 2025 07:00AM TScan Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
Mar 5, 2025 07:00AM
Dec 9, 2024 05:45PM
Dec 2, 2024 07:00AM
Aug 12, 2024 07:00AM
May 29, 2024 07:02AM
May 29, 2024 07:00AM
Mar 6, 2024 07:00AM TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Jan 4, 2024 07:00AM
Nov 9, 2023 07:00AM
Nov 6, 2023 07:00AM
Aug 29, 2023 07:00AM
Aug 29, 2023 07:00AM
Aug 10, 2023 07:00AM
Jun 6, 2023 07:03AM TScan Therapeutics (TCRX) Announces FDA Clearance of Investigational New Drug Application for TSC-200-A0201 Targeting HPV16 to Treat Solid Tumors
Jun 6, 2023 07:00AM
Mar 31, 2023 08:00AM
Mar 31, 2023 08:00AM
Mar 31, 2023 08:00AM
Mar 8, 2023 07:00AM
Mar 8, 2023 07:00AM
Jan 23, 2023 07:00AM TScan Therapeutics, Inc (TCRX) Announces FDA Clearance of Three Investigational NDAs for Treatment of Solid Tumors
Jan 23, 2023 07:00AM
Jan 23, 2023 07:00AM
Jan 5, 2023 07:00AM
Jan 5, 2023 07:00AM
Nov 9, 2022 07:00AM
Nov 9, 2022 07:00AM
Aug 10, 2022 07:00AM TScan Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Progress
Aug 10, 2022 07:00AM
May 31, 2022 07:05AM
May 31, 2022 07:00AM
May 31, 2022 07:00AM
May 9, 2022 07:00AM
May 9, 2022 07:00AM
Mar 9, 2022 07:00AM TScan Therapeutics Reports Full Year 2021 Financial Results and Highlights Key 2022 Priorities
Mar 9, 2022 07:00AM

323,712 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All